Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics

Christian Lattermann; Chilan B.G. Leite; David D. Frisbie; Theodore S. Schlegel; Larry R. Bramlage; Thomas Koch; Christopher Centeno; Laurie R. Goodrich; Brian Johnstone; Rocci Trumper; Ashlee Watts; Christopher Little; Frank Barry; Farsh Guilak; C. Wayne McIlwraith

doi:10.1016/j.jcjp.2022.100055

Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics

Christian Lattermann, Chilan B.G. Leite, David D. Frisbie, Theodore S. Schlegel, Larry R. Bramlage, Thomas Koch, Christopher Centeno, Laurie R. Goodrich, Brian Johnstone, Rocci Trumper, Ashlee Watts, Christopher Little, Frank Barry, Farsh Guilak, C. Wayne McIlwraith

Orthopaedics and Rehabilitation

Research output: Contribution to journal › Article › peer-review

Abstract

Readily available and effective therapeutic approaches are increasingly required to overcome the growing demand for optimized management of musculoskeletal degenerative conditions. The use of biologic therapies has been gaining ground in the orthopedic field by showing promising results. In order to review the current status of orthobiologics and to discuss the potential risks, benefits, and challenges of their implementation, a recent expert conference hosted by the C. Wayne McIlwraith Translational Medicine Institute (TMI), and funded by the Dorothy Havemeyer Foundation was held at Colorado State University, in conjunction with the official Opening of the TMI. This review summarizes the conference findings highlighting the scientific challenges, safety concerns, and translation of orthobiologics to clinical practice.

Original language	English (US)
Article number	100055
Journal	Journal of Cartilage and Joint Preservation
Volume	2
Issue number	3
DOIs	https://doi.org/10.1016/j.jcjp.2022.100055
State	Published - Sep 2022

Keywords

Orthobiologics
Platelet-rich plasma
Regenerative medicine
Stem cell therapy

ASJC Scopus subject areas

Surgery
Immunology and Allergy
Rheumatology
Orthopedics and Sports Medicine
Biochemistry, Genetics and Molecular Biology (miscellaneous)

Access to Document

10.1016/j.jcjp.2022.100055

Cite this

Lattermann, C., Leite, C. B. G., Frisbie, D. D., Schlegel, T. S., Bramlage, L. R., Koch, T., Centeno, C., Goodrich, L. R., Johnstone, B., Trumper, R., Watts, A., Little, C., Barry, F., Guilak, F., & McIlwraith, C. W. (2022). Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics. Journal of Cartilage and Joint Preservation, 2(3), Article 100055. https://doi.org/10.1016/j.jcjp.2022.100055

Lattermann, C, Leite, CBG, Frisbie, DD, Schlegel, TS, Bramlage, LR, Koch, T, Centeno, C, Goodrich, LR, Johnstone, B, Trumper, R, Watts, A, Little, C, Barry, F, Guilak, F & McIlwraith, CW 2022, 'Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics', Journal of Cartilage and Joint Preservation, vol. 2, no. 3, 100055. https://doi.org/10.1016/j.jcjp.2022.100055

@article{825d60ef37a14d19b730288f3c4a22ad,

title = "Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics",

abstract = "Readily available and effective therapeutic approaches are increasingly required to overcome the growing demand for optimized management of musculoskeletal degenerative conditions. The use of biologic therapies has been gaining ground in the orthopedic field by showing promising results. In order to review the current status of orthobiologics and to discuss the potential risks, benefits, and challenges of their implementation, a recent expert conference hosted by the C. Wayne McIlwraith Translational Medicine Institute (TMI), and funded by the Dorothy Havemeyer Foundation was held at Colorado State University, in conjunction with the official Opening of the TMI. This review summarizes the conference findings highlighting the scientific challenges, safety concerns, and translation of orthobiologics to clinical practice.",

keywords = "Orthobiologics, Platelet-rich plasma, Regenerative medicine, Stem cell therapy",

author = "Christian Lattermann and Leite, {Chilan B.G.} and Frisbie, {David D.} and Schlegel, {Theodore S.} and Bramlage, {Larry R.} and Thomas Koch and Christopher Centeno and Goodrich, {Laurie R.} and Brian Johnstone and Rocci Trumper and Ashlee Watts and Christopher Little and Frank Barry and Farsh Guilak and McIlwraith, {C. Wayne}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = sep,

doi = "10.1016/j.jcjp.2022.100055",

language = "English (US)",

volume = "2",

journal = "Journal of Cartilage and Joint Preservation",

issn = "2667-2545",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Orthobiologics in orthopedic applications

T2 - a report from the TMI Havemeyer meeting on orthobiologics

AU - Lattermann, Christian

AU - Leite, Chilan B.G.

AU - Frisbie, David D.

AU - Schlegel, Theodore S.

AU - Bramlage, Larry R.

AU - Koch, Thomas

AU - Centeno, Christopher

AU - Goodrich, Laurie R.

AU - Johnstone, Brian

AU - Trumper, Rocci

AU - Watts, Ashlee

AU - Little, Christopher

AU - Barry, Frank

AU - Guilak, Farsh

AU - McIlwraith, C. Wayne

PY - 2022/9

Y1 - 2022/9

N2 - Readily available and effective therapeutic approaches are increasingly required to overcome the growing demand for optimized management of musculoskeletal degenerative conditions. The use of biologic therapies has been gaining ground in the orthopedic field by showing promising results. In order to review the current status of orthobiologics and to discuss the potential risks, benefits, and challenges of their implementation, a recent expert conference hosted by the C. Wayne McIlwraith Translational Medicine Institute (TMI), and funded by the Dorothy Havemeyer Foundation was held at Colorado State University, in conjunction with the official Opening of the TMI. This review summarizes the conference findings highlighting the scientific challenges, safety concerns, and translation of orthobiologics to clinical practice.

AB - Readily available and effective therapeutic approaches are increasingly required to overcome the growing demand for optimized management of musculoskeletal degenerative conditions. The use of biologic therapies has been gaining ground in the orthopedic field by showing promising results. In order to review the current status of orthobiologics and to discuss the potential risks, benefits, and challenges of their implementation, a recent expert conference hosted by the C. Wayne McIlwraith Translational Medicine Institute (TMI), and funded by the Dorothy Havemeyer Foundation was held at Colorado State University, in conjunction with the official Opening of the TMI. This review summarizes the conference findings highlighting the scientific challenges, safety concerns, and translation of orthobiologics to clinical practice.

KW - Orthobiologics

KW - Platelet-rich plasma

KW - Regenerative medicine

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=85143488699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143488699&partnerID=8YFLogxK

U2 - 10.1016/j.jcjp.2022.100055

DO - 10.1016/j.jcjp.2022.100055

M3 - Article

AN - SCOPUS:85143488699

SN - 2667-2545

VL - 2

JO - Journal of Cartilage and Joint Preservation

JF - Journal of Cartilage and Joint Preservation

IS - 3

M1 - 100055

ER -

Orthobiologics in orthopedic applications: a report from the TMI Havemeyer meeting on orthobiologics

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this